(904) 998-0854
Podcasts

S2E3: Evinacumab: A new therapeutic option to treat dyslipidemia

Alan Brown, MD, FACC, MNLA · Robert S. Rosenson, MD, FNLA
Posted April 5, 2021

Host

Alan S. Brown, MD, FACC, MNLA
Specialist in Clinical Lipidology
Professor of Cardiovascular Medicine
Wake Forest School of Medicine

Guest

Robert S. Rosenson, MD, FNLA
Director, Metabolism and Lipids, Mount Sinai Health System
Professor of Medicine and Cardiology
Mount Sinai Heart Icahn School of Medicine

Join Dr. Alan Brown and Dr. Robert Rosenson as they discuss evinacumab, a new therapeutic option for treating dyslipidemia.

    Recent Podcasts

    Podcasts
    Episode 6: Industry Innovations: Guidelines in Action
    Play | Posted 07/29/2026
    Podcasts
    Episode 5: Statin Intolerance in Focus: Navigating Side Effects, Patient Concerns, and the Path to Optimal LDL Lowering
    Play | Posted 07/14/2026
    Podcasts
    S7E8: Thinking Long-Term: LDL Exposure, Longevity Medicine, and the Future of Cardiovascular Prevention
    Play | Posted 07/01/2026
    Podcasts
    S1E1: Clinical Pearls on Provider Methods for Obtaining Prior Authorizations for PCSK9i
    Play | Posted 05/28/2026
    Podcasts
    S1E2: General Gaps in FH Care
    Play | Posted 05/28/2026
    View All Podcasts